BIOMAT Database Logo BIOMAT Database Logo

Deconvolution analysis of the regeneration process of mitomycin C from prodrug in a muscle perfusion system based on statistical moment theory. 1987

T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida

UI MeSH Term Description Entries
D008297 Male Males
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Disposition characteristics of lipophilic mitomycin C prodrug in an intra-arterial muscle infusion system.
December 1987, Chemical & pharmaceutical bulletin,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Effect of plasma protein binding on drug disposition in muscle tissue: application of statistical moment analysis and network theory to in situ local single-pass perfusion system.
April 1988, Journal of pharmacokinetics and biopharmaceutics,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Synthesis and controlled release of mitomycin C from a chitosan-based polymeric prodrug.
November 2011, Journal of controlled release : official journal of the Controlled Release Society,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theory.
February 1985, Drug intelligence & clinical pharmacy,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.
December 1985, Journal of pharmacokinetics and biopharmaceutics,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate.
May 1985, Journal of pharmacobio-dynamics,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.
January 1989, Journal of pharmaceutical sciences,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.
January 1984, Drug metabolism and disposition: the biological fate of chemicals,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
The effect of mitomycin-C on the healing process in rabbit extraocular muscle surgery.
April 1999, Ophthalmic surgery and lasers,
T Kakutani, and R Atsumi, and E Sumimoto, and M Hashida
Statistical properties of cerebral CT perfusion imaging systems. Part II. Deconvolution-based systems.
November 2019, Medical physics,
Copied contents to your clipboard!